Tag: Needham & Co.

NEW YORK – Providers expect to see double-digit growth in their sleep patient volume over the next 12 months as flow-generator availability improves, according to the first quarter 2023 HME Sleep and Oxygen Survey from Needham.  Respondents reported that they have been able to purchase their desired flow generators within required timeframes as follows: Philips, 15.6% (up from 12.1% in Q3 2022); Fisher & Paykel, 25% (up from 9.4% in Q3 2022); and ResMed, 61.4% (up from 39.2% in Q3 2022).  The...

NEW YORK – HME providers saw a 6.3% decline in their sleep patient volume in the last 12 months, but they expect double-digit growth in the next 12 months, according to the third quarter HME Sleep and Oxygen Survey from Needham.  The decline in sleep is mainly due to a shortage in flow generators. The eventual re-entry of Philips into the flow generator market appears likely to come mostly at the expense of smaller competitors rather than ResMed, according to the survey.  Respondents...

NEW YORK - The majority of HME providers are reducing or delaying orders for oxygen and CPAP equipment, but that is likely to be temporary, according to a new survey for the fourth quarter of 2018 from Needham & Company.Sixty three percent of respondents said they would reduce or delay orders for oxygen equipment in response to an any willing provider provision set to go into effect Jan. 1 for Medicare, according to the survey of 150 providers.Respondents said they would also reduce or delay orders...

BOSTON - Sleep center patient volume grew 7% in the last 12 months and is expected to grow 9% in the next 12 months, according to the results of a new survey conducted by Needham & Co. ResMed looks likely to lose 2% of flow generator prescription share, but gain branded mask prescription share. For flow generators, Respironics' share is up 1.1%, Fisher & Paykel's share is flat and other companies' share is up .8%. ResMed's mask ratings are slightly above its competitors in all three mask categories....

BOSTON - HME providers will continue to increase adoption of portable oxygen concentrators, to the tune of about 30% over the next 12 months, according to a 2Q 2018 survey on oxygen and sleep trends from Needham & Co. Applied Home Healthcare's OxyGo Fit and OxyGo were the highest rated POCs at 5.9 and 5.8 out of 7, followed by Inogen's G4 and G3, both at 5.7, and Respironics' SimplyGo Mini at 5.1. Survey respondents identify an average of 42% of their ambulatory patients as candidates...